BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Elmunzer BJ, Hayward RA, Schoenfeld PS, Saini SD, Deshpande A, Waljee AK. Effect of flexible sigmoidoscopy-based screening on incidence and mortality of colorectal cancer: a systematic review and meta-analysis of randomized controlled trials. PLoS Med. 2012;9:e1001352. [PMID: 23226108 DOI: 10.1371/journal.pmed.1001352] [Cited by in Crossref: 134] [Cited by in F6Publishing: 124] [Article Influence: 13.4] [Reference Citation Analysis]
Number Citing Articles
1 Alnabulsi A, Murray GI. Integrative analysis of the colorectal cancer proteome: potential clinical impact. Expert Rev Proteomics 2016;13:917-27. [PMID: 27598033 DOI: 10.1080/14789450.2016.1233062] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
2 Parker RK, Mwachiro MM, Ranketi SS, Mogambi FC, Topazian HM, White RE. Curative Surgery Improves Survival for Colorectal Cancer in Rural Kenya. World J Surg 2020;44:30-6. [DOI: 10.1007/s00268-019-05234-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Chiu H, Hsu W, Chang L, Wu M. Colorectal Cancer Screening in Asia. Curr Gastroenterol Rep 2017;19. [DOI: 10.1007/s11894-017-0587-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
4 Gimeno-García AZ, Hernández-Álvarez-de-Buylla N, Nicolás-Pérez D, Carrillo M, Hernández G, Quintero E. Colorectal cancer screening in the familial risk population: Is colonoscopy still the strategy of choice? Gastroenterol Hepatol 2016;39:352-60. [PMID: 26547615 DOI: 10.1016/j.gastrohep.2015.09.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
5 Ladabaum U, Mannalithara A, Desai M, Sehgal M, Singh G. Age-Specific Rates and Time-Courses of Gastrointestinal and Nongastrointestinal Complications Associated With Screening/Surveillance Colonoscopy. Am J Gastroenterol 2021. [PMID: 34693917 DOI: 10.14309/ajg.0000000000001531] [Reference Citation Analysis]
6 Dreier M, Borutta B, Seidel G, Münch I, Kramer S, Töppich J, Dierks ML, Walter U. Communicating the benefits and harms of colorectal cancer screening needed for an informed choice: a systematic evaluation of leaflets and booklets. PLoS One 2014;9:e107575. [PMID: 25215867 DOI: 10.1371/journal.pone.0107575] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
7 Domènech X, Garcia M, Benito L, Binefa G, Vidal C, Milà N, Moreno V. [Interval cancers and episode sensitivity in population-based screening programmes for colorectal cancer: a systematic review]. Gac Sanit 2015;29:464-71. [PMID: 26341155 DOI: 10.1016/j.gaceta.2015.07.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
8 Wang J, Cho NL, Zauber AG, Hsu M, Dawson D, Srivastava A, Mitchell-Richards KA, Markowitz SD, Bertagnolli MM. Chemopreventive Efficacy of the Cyclooxygenase-2 (Cox-2) Inhibitor, Celecoxib, Is Predicted by Adenoma Expression of Cox-2 and 15-PGDH. Cancer Epidemiol Biomarkers Prev 2018;27:728-36. [PMID: 29769213 DOI: 10.1158/1055-9965.EPI-17-0573] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
9 Wang J, Gao J, Xu HL, Qian Y, Xie L, Yu H, Qian BY. Citrus fruit intake and lung cancer risk: A meta-analysis of observational studies. Pharmacol Res 2021;166:105430. [PMID: 33529754 DOI: 10.1016/j.phrs.2021.105430] [Reference Citation Analysis]
10 Garborg K, Holme Ø, Løberg M, Kalager M, Adami HO, Bretthauer M. Current status of screening for colorectal cancer. Ann Oncol. 2013;24:1963-1972. [PMID: 23619033 DOI: 10.1093/annonc/mdt157] [Cited by in Crossref: 64] [Cited by in F6Publishing: 69] [Article Influence: 7.1] [Reference Citation Analysis]
11 Antoniou T, Jembere N, Saskin R, Kopp A, Glazier RH. A population-based study of the extent of colorectal cancer screening in men with HIV. BMC Health Serv Res 2015;15:51. [PMID: 25638206 DOI: 10.1186/s12913-015-0711-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
12 Patel SS, Kilgore ML. Cost Effectiveness of Colorectal Cancer Screening Strategies. Cancer Control. 2015;22:248-258. [PMID: 26068773 DOI: 10.1177/107327481502200219] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 6.5] [Reference Citation Analysis]
13 Chan AT, Ladabaum U. Where Do We Stand With Aspirin for the Prevention of Colorectal Cancer? The USPSTF Recommendations. Gastroenterology 2016;150:14-8. [PMID: 26602220 DOI: 10.1053/j.gastro.2015.11.018] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
14 Asadzadeh Aghdaei H, Nazemalhosseini Mojarad E, Ashtari S, Pourhoseingholi MA, Chaleshi V, Anaraki F, Haghazali M, Zali MR. Polyp detection rate and pathological features in patients undergoing a comprehensive colonoscopy screening. World J Gastrointest Pathophysiol 2017; 8(1): 3-10 [PMID: 28251034 DOI: 10.4291/wjgp.v8.i1.3] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
15 Symonds EL, Pedersen SK, Baker RT, Murray DH, Gaur S, Cole SR, Gopalsamy G, Mangira D, LaPointe LC, Young GP. A Blood Test for Methylated BCAT1 and IKZF1 vs. a Fecal Immunochemical Test for Detection of Colorectal Neoplasia. Clin Transl Gastroenterol. 2016;7:e137. [PMID: 26765125 DOI: 10.1038/ctg.2015.67] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 7.7] [Reference Citation Analysis]
16 Gerber DE, Hamann HA, Santini NO, Abbara S, Chiu H, McGuire M, Quirk L, Zhu H, Lee SJC. Patient navigation for lung cancer screening in an urban safety-net system: Protocol for a pragmatic randomized clinical trial. Contemp Clin Trials 2017;60:78-85. [PMID: 28689056 DOI: 10.1016/j.cct.2017.07.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
17 Garcia M, Domènech X, Vidal C, Torné E, Milà N, Binefa G, Benito L, Moreno V. Interval cancers in a population-based screening program for colorectal cancer in catalonia, Spain. Gastroenterol Res Pract 2015;2015:672410. [PMID: 25802515 DOI: 10.1155/2015/672410] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
18 Tinmouth J, Vella ET, Baxter NN, Dubé C, Gould M, Hey A, Ismaila N, McCurdy BR, Paszat L. Colorectal Cancer Screening in Average Risk Populations: Evidence Summary. Can J Gastroenterol Hepatol 2016;2016:2878149. [PMID: 27597935 DOI: 10.1155/2016/2878149] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
19 Bannister-Tyrrell M, Miladinovic B, Roberts CL, Ford JB. Adjustment for compliance behavior in trials of epidural analgesia in labor using instrumental variable meta-analysis. J Clin Epidemiol 2015;68:525-33. [PMID: 25592169 DOI: 10.1016/j.jclinepi.2014.11.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
20 Young GP, Rabeneck L, Winawer SJ. The Global Paradigm Shift in Screening for Colorectal Cancer. Gastroenterology. 2019;156:843-851.e2. [PMID: 30776340 DOI: 10.1053/j.gastro.2019.02.006] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 10.3] [Reference Citation Analysis]
21 Bjørge T, Gissler M, Ording AG, Engeland A, Glimelius I, Leinonen M, Sørensen HT, Tretli S, Ekbom A, Troisi R, Grotmol T. Reproductive history and risk of colorectal adenocarcinoma in parous women: a Nordic population-based case-control study. Br J Cancer 2016;115:1416-20. [PMID: 27701386 DOI: 10.1038/bjc.2016.315] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
22 Asteria CR, Lucchini G, Guarda L, Ricci P, Pagani M, Boccia L. The detection of interval colorectal cancers following screening by fecal immunochemical test may predict worse outcomes and prompt ethical concerns: a 6-year population-based cohort study in a full district. Eur J Cancer Prev 2019;28:17-26. [PMID: 29111981 DOI: 10.1097/CEJ.0000000000000416] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
23 Hoff G. Different standards for healthy screenees than patients in routine clinics? World J Gastroenterol 2013; 19(46): 8527-8530 [PMID: 24379569 DOI: 10.3748/wjg.v19.i46.8527] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
24 Autier P, Boniol M. Mammography screening: A major issue in medicine. Eur J Cancer 2018;90:34-62. [PMID: 29272783 DOI: 10.1016/j.ejca.2017.11.002] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 9.2] [Reference Citation Analysis]
25 Decker KM, Singh H. Reducing inequities in colorectal cancer screening in North America. J Carcinog 2014;13:12. [PMID: 25506266 DOI: 10.4103/1477-3163.144576] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
26 Charters TJ, Strumpf EC, Sewitch MJ. Effectiveness of an organized colorectal cancer screening program on increasing adherence in asymptomatic average-risk Canadians. BMC Health Serv Res 2013;13:449. [PMID: 24168208 DOI: 10.1186/1472-6963-13-449] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
27 Lu M, Luo X, Li N, Chen H, Dai M. Diagnostic Accuracy Of Fecal Occult Blood Tests For Detecting Proximal Versus Distal Colorectal Neoplasia: A Systematic Review And Meta-Analysis. Clin Epidemiol 2019;11:943-54. [PMID: 31695506 DOI: 10.2147/CLEP.S213677] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.7] [Reference Citation Analysis]
28 Maida M, Macaluso FS, Ianiro G, Mangiola F, Sinagra E, Hold G, Maida C, Cammarota G, Gasbarrini A, Scarpulla G. Screening of colorectal cancer: present and future. Expert Rev Anticancer Ther. 2017;17:1131-1146. [PMID: 29022408 DOI: 10.1080/14737140.2017.1392243] [Cited by in Crossref: 57] [Cited by in F6Publishing: 49] [Article Influence: 11.4] [Reference Citation Analysis]
29 van de Velde CJ, Aristei C, Boelens PG, Beets-Tan RG, Blomqvist L, Borras JM, van den Broek CB, Brown G, Coebergh JW, Cutsem EV, Espin E, Gore-Booth J, Glimelius B, Haustermans K, Henning G, Iversen LH, Han van Krieken J, Marijnen CA, Mroczkowski P, Nagtegaal I, Naredi P, Ortiz H, Påhlman L, Quirke P, Rödel C, Roth A, Rutten HJ, Schmoll HJ, Smith J, Tanis PJ, Taylor C, Wibe A, Gambacorta MA, Meldolesi E, Wiggers T, Cervantes A, Valentini V; European Registration of Cancer Care. EURECCA colorectal: multidisciplinary mission statement on better care for patients with colon and rectal cancer in Europe. Eur J Cancer 2013;49:2784-90. [PMID: 23769991 DOI: 10.1016/j.ejca.2013.04.032] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 6.9] [Reference Citation Analysis]
30 Ladabaum U, Mannalithara A. Comparative Effectiveness and Cost Effectiveness of a Multitarget Stool DNA Test to Screen for Colorectal Neoplasia. Gastroenterology. 2016;151:427-439.e6. [PMID: 27311556 DOI: 10.1053/j.gastro.2016.06.003] [Cited by in Crossref: 65] [Cited by in F6Publishing: 50] [Article Influence: 10.8] [Reference Citation Analysis]
31 Sovich JL, Sartor Z, Misra S. Developments in Screening Tests and Strategies for Colorectal Cancer. Biomed Res Int 2015;2015:326728. [PMID: 26504799 DOI: 10.1155/2015/326728] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
32 Dreier M, Borutta B, Seidel G, Kreusel I, Töppich J, Bitzer EM, Dierks ML, Walter U. Development of a comprehensive list of criteria for evaluating consumer education materials on colorectal cancer screening. BMC Public Health 2013;13:843. [PMID: 24028691 DOI: 10.1186/1471-2458-13-843] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
33 Murphy CC. Colorectal Cancer in the Young: Does Screening Make Sense? Curr Gastroenterol Rep. 2019;21:28. [PMID: 31098760 DOI: 10.1007/s11894-019-0695-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
34 Hill J. Follow up after curative colorectal cancer resection - aggregation of marginal gains. Colorectal Dis 2014;16:575-6. [PMID: 25039451 DOI: 10.1111/codi.12650] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
35 Rees CJ, Bevan R, Zimmermann-Fraedrich K, Rutter MD, Rex D, Dekker E, Ponchon T, Bretthauer M, Regula J, Saunders B, Hassan C, Bourke MJ, Rösch T. Expert opinions and scientific evidence for colonoscopy key performance indicators. Gut 2016;65:2045-60. [PMID: 27802153 DOI: 10.1136/gutjnl-2016-312043] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 6.7] [Reference Citation Analysis]
36 Hallajzadeh J, Maleki Dana P, Mobini M, Asemi Z, Mansournia MA, Sharifi M, Yousefi B. Targeting of oncogenic signaling pathways by berberine for treatment of colorectal cancer. Med Oncol 2020;37:49. [PMID: 32303850 DOI: 10.1007/s12032-020-01367-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
37 Symonds EL, Young GP. Blood Tests for Colorectal Cancer Screening in the Standard Risk Population. Curr Colorectal Cancer Rep 2015;11:397-407. [DOI: 10.1007/s11888-015-0293-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
38 Wang YW, Chen HH, Wu MS, Chiu HM; Taiwanese Nationwide Colorectal Cancer Screening Program. Current status and future challenge of population-based organized colorectal cancer screening: Lesson from the first decade of Taiwanese program. J Formos Med Assoc 2018;117:358-64. [PMID: 28988890 DOI: 10.1016/j.jfma.2017.09.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
39 Kerrison RS, von Wagner C, Green T, Gibbins M, Macleod U, Hughes M, Rees CJ, Duffy S, Mcgregor LM. Rapid review of factors associated with flexible sigmoidoscopy screening use. Preventive Medicine 2019;120:8-18. [DOI: 10.1016/j.ypmed.2018.12.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
40 Kerrison RS, Prentice A, Marshall S, Choglay S, Stoffel S, Rees C, von Wagner C. Implementation of long-term non-participant reminders for flexible sigmoidoscopy screening. Prev Med Rep 2021;21:101308. [PMID: 33505841 DOI: 10.1016/j.pmedr.2020.101308] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Rabeneck L, Paszat LF, Hilsden RJ, McGregor SE, Hsieh E, M Tinmouth J, Baxter NN, Saskin R, Ruco A, Stock D. Advanced proximal neoplasia of the colon in average-risk adults. Gastrointest Endosc 2014;80:660-7. [PMID: 24679656 DOI: 10.1016/j.gie.2014.02.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
42 Holme Ø, Schoen RE, Senore C, Segnan N, Hoff G, Løberg M, Bretthauer M, Adami HO, Kalager M. Effectiveness of flexible sigmoidoscopy screening in men and women and different age groups: pooled analysis of randomised trials. BMJ 2017;356:i6673. [PMID: 28087510 DOI: 10.1136/bmj.i6673] [Cited by in Crossref: 61] [Cited by in F6Publishing: 49] [Article Influence: 12.2] [Reference Citation Analysis]
43 Huck MB, Bohl JL. Colonic Polyps: Diagnosis and Surveillance. Clin Colon Rectal Surg 2016;29:296-305. [PMID: 31777460 DOI: 10.1055/s-0036-1584091] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
44 Krylov NN, Pyatenko EA, Komissarov AB. [Comparative analysis of colorectal cancer screening approaches]. Khirurgiia (Mosk) 2017;:92-7. [PMID: 29186105 DOI: 10.17116/hirurgia20171192-97] [Reference Citation Analysis]
45 Armaroli P, Villain P, Suonio E, Almonte M, Anttila A, Atkin WS, Dean PB, de Koning HJ, Dillner L, Herrero R, Kuipers EJ, Lansdorp-vogelaar I, Minozzi S, Paci E, Regula J, Törnberg S, Segnan N. European Code against Cancer, 4th Edition: Cancer screening. Cancer Epidemiology 2015;39:S139-52. [DOI: 10.1016/j.canep.2015.10.021] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 6.6] [Reference Citation Analysis]
46 Steffen A, Weber MF, Roder DM, Banks E. Colorectal cancer screening and subsequent incidence of colorectal cancer: results from the 45 and Up Study. Med J Aust 2014;201:523-7. [PMID: 25358576 DOI: 10.5694/mja14.00197] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
47 Altobelli E, Lattanzi A, Paduano R, Varassi G, di Orio F. Colorectal cancer prevention in Europe: burden of disease and status of screening programs. Prev Med. 2014;62:132-141. [PMID: 24530610 DOI: 10.1016/j.ypmed.2014.02.010] [Cited by in Crossref: 104] [Cited by in F6Publishing: 108] [Article Influence: 13.0] [Reference Citation Analysis]
48 Facciorusso A, Antonino M, Di Maso M, Barone M, Muscatiello N. Non-polypoid colorectal neoplasms: Classification, therapy and follow-up. World J Gastroenterol 2015; 21(17): 5149-5157 [PMID: 25954088 DOI: 10.3748/wjg.v21.i17.5149] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
49 Ladabaum U. Occult blood in faeces: a window into health beyond the colorectum? Gut 2018;67:2079-80. [PMID: 30012725 DOI: 10.1136/gutjnl-2018-316762] [Reference Citation Analysis]
50 Oliveira MM, Latorre MDRDO, Tanaka LF, Rossi BM, Curado MP. Disparities in colorectal cancer mortality across Brazilian States. Rev Bras Epidemiol 2018;21:e180012. [PMID: 30156659 DOI: 10.1590/1980-549720180012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
51 Kahi CJ. Reviewing the Evidence that Polypectomy Prevents Cancer. Gastrointestinal Endoscopy Clinics of North America 2019;29:577-85. [DOI: 10.1016/j.giec.2019.05.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
52 Parfrey PS, Dicks E, Parfrey O, McNicholas PJ, Noseworthy H, Woods MO, Negriin C, Green J. Evaluation of a population-based approach to familial colorectal cancer. Clin Genet 2017;91:672-82. [PMID: 27696385 DOI: 10.1111/cge.12877] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
53 Saito Y, Oka S, Kawamura T, Shimoda R, Sekiguchi M, Tamai N, Hotta K, Matsuda T, Misawa M, Tanaka S, Iriguchi Y, Nozaki R, Yamamoto H, Yoshida M, Fujimoto K, Inoue H. Colonoscopy screening and surveillance guidelines. Dig Endosc 2021;33:486-519. [PMID: 33713493 DOI: 10.1111/den.13972] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
54 Castro I, Estevez P, Cubiella J, Hernandez V, González-Mao C, Rivera C, Iglesias F, Cid L, Soto S, de-Castro L, Vega P, Hermo JA, Macenlle R, Martínez A, Cid E, Gil I, Larzabal M, Bujanda L, Castells A; COLONPREV study investigators. Diagnostic performance of fecal immunochemical test and sigmoidoscopy for advanced right-sided colorectal neoplasms. Dig Dis Sci 2015;60:1424-32. [PMID: 25407805 DOI: 10.1007/s10620-014-3434-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
55 Coretti S, Ruggeri M, Dibidino R, Gitto L, Marcellusi A, Mennini FS, Cicchetti A. Economic evaluation of colorectal cancer screening programs: Affordability for the health service. J Med Screen 2020;27:186-93. [PMID: 31948342 DOI: 10.1177/0969141319898732] [Reference Citation Analysis]
56 Benton SC, Seaman HE, Halloran SP. Faecal occult blood testing for colorectal cancer screening: the past or the future. Curr Gastroenterol Rep. 2015;17:428. [PMID: 25673567 DOI: 10.1007/s11894-015-0428-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
57 Hadjipetrou A, Anyfantakis D, Galanakis CG, Kastanakis M, Kastanakis S. Colorectal cancer, screening and primary care: A mini literature review. World J Gastroenterol 2017; 23(33): 6049-6058 [PMID: 28970720 DOI: 10.3748/wjg.v23.i33.6049] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 33] [Article Influence: 7.2] [Reference Citation Analysis]
58 Lorentzen JA, Grzyb K, De Angelis PM, Hoff G, Eide TJ, Andresen PA. Oncogene Mutations in Colorectal Polyps Identified in the Norwegian Colorectal Cancer Prevention (NORCCAP) Screening Study. Clin Med Insights Pathol 2016;9:19-28. [PMID: 27656095 DOI: 10.4137/CPath.s40143] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
59 Brenner H, Hoffmeister M. [Colorectal cancer screening: evidence and implementation]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014;57:302-306. [PMID: 24562704 DOI: 10.1007/s00103-013-1911-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
60 Shroff J, Thosani N, Batra S, Singh H, Guha S. Reduced incidence and mortality from colorectal cancer with flexible-sigmoidoscopy screening: A meta-analysis. World J Gastroenterol 2014; 20(48): 18466-18476 [PMID: 25561818 DOI: 10.3748/wjg.v20.i48.18466] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
61 Triantafillidis JK, Vagianos C, Malgarinos G. Colonoscopy in Colorectal Cancer Screening: Current Aspects. Indian J Surg Oncol 2015;6:237-50. [PMID: 27217671 DOI: 10.1007/s13193-015-0410-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
62 Carlomagno C, De Stefano A, Rosanova M, De Falco S, Attademo L, Fiore G, De Placido S. Multiple treatment lines and prognosis in metastatic colorectal cancer patients. Cancer Metastasis Rev 2019;38:307-13. [PMID: 30003458 DOI: 10.1007/s10555-018-9748-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
63 Rabeneck L, Lansdorp-Vogelaar I. Assessment of a cancer screening program. Best Pract Res Clin Gastroenterol 2015;29:979-85. [PMID: 26651258 DOI: 10.1016/j.bpg.2015.09.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
64 Young GP, Symonds EL, Allison JE, Cole SR, Fraser CG, Halloran SP, Kuipers EJ, Seaman HE. Advances in Fecal Occult Blood Tests: the FIT revolution. Dig Dis Sci. 2015;60:609-622. [PMID: 25492500 DOI: 10.1007/s10620-014-3445-3] [Cited by in Crossref: 94] [Cited by in F6Publishing: 83] [Article Influence: 11.8] [Reference Citation Analysis]
65 Morois S, Cottet V, Racine A, Clavel-Chapelon F, Carbonnel F, Bastide N, Boutron-Ruault MC. Colonoscopy reduced distal colorectal cancer risk and excess cancer risk associated with family history. Cancer Causes Control. 2014;25:1329-1336. [PMID: 25048603 DOI: 10.1007/s10552-014-0438-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
66 Keys MT, Serra-Burriel M, Martínez-Lizaga N, Pellisé M, Balaguer F, Sánchez A, Bernal-Delgado E, Castells A. Population-based organized screening by faecal immunochemical testing and colorectal cancer mortality: a natural experiment. Int J Epidemiol 2021;50:143-55. [PMID: 33211822 DOI: 10.1093/ije/dyaa166] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Ladabaum U, Mannalithara A, Brill JV, Levin Z, Bundorf KM. Contrasting Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening Under Commercial Insurance vs. Medicare. Am J Gastroenterol 2018;113:1836-47. [PMID: 29904156 DOI: 10.1038/s41395-018-0106-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
68 Michel M, Kaps L, Maderer A, Galle PR, Moehler M. The Role of p53 Dysfunction in Colorectal Cancer and Its Implication for Therapy. Cancers (Basel) 2021;13:2296. [PMID: 34064974 DOI: 10.3390/cancers13102296] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
69 Quintero E, Alarcón-Fernández O, Jover R. [Colonoscopy quality control as a requirement of colorectal cancer screening]. Gastroenterol Hepatol 2013;36:597-605. [PMID: 23769425 DOI: 10.1016/j.gastrohep.2013.02.005] [Cited by in Crossref: 6] [Article Influence: 0.7] [Reference Citation Analysis]
70 Jansen EE, Zielonke N, Gini A, Anttila A, Segnan N, Vokó Z, Ivanuš U, Mckee M, de Koning HJ, de Kok IM, Veerus P, Anttila A, Heinävaara S, Sarkeala T, Csanádi M, Pitter J, Széles G, Vokó Z, Minozzi S, Segnan N, Senore C, van Ballegooijen M, Driesprong - de Kok I, Gini A, Heijnsdijk E, Jansen E, de Koning H, Lansdorp – Vogelaar I, van Ravesteyn N, Zielonke N, Ivanus U, Jarm K, Mlakar DN, Primic-žakelj M, Mckee M, Priaulx J. Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review. European Journal of Cancer 2020;127:207-23. [DOI: 10.1016/j.ejca.2019.12.013] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 12.5] [Reference Citation Analysis]
71 Kerrison RS, McGregor LM, Counsell N, Marshall S, Prentice A, Isitt J, Rees CJ, von Wagner C. Use of Two Self-referral Reminders and a Theory-Based Leaflet to Increase the Uptake of Flexible Sigmoidoscopy in the English Bowel Scope Screening Program: Results From a Randomized Controlled Trial in London. Ann Behav Med 2018;52:941-51. [PMID: 30346495 DOI: 10.1093/abm/kax068] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
72 Tariq H, Kamal MU, Sapkota B, ElShikh F, Pirzada UA, Pullela N, Azam S, Zhang A, Baiomi A, Abbas H, Makker J, Balar B, Ihimoyan A, Daniel M, Dev A. Evaluation of the combined effect of factors influencing bowel preparation and adenoma detection rates in patients undergoing colonoscopy. BMJ Open Gastroenterol 2019;6:e000254. [PMID: 30740233 DOI: 10.1136/bmjgast-2018-000254] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Kahi CJ, Vemulapalli KC, Snover DC, Abdel Jawad KH, Cummings OW, Rex DK. Findings in the distal colorectum are not associated with proximal advanced serrated lesions. Clin Gastroenterol Hepatol 2015;13:345-51. [PMID: 25083562 DOI: 10.1016/j.cgh.2014.07.044] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
74 Wilt TJ, Scardino PT, Carlsson SV, Basch E. Prostate-specific antigen screening in prostate cancer: perspectives on the evidence. J Natl Cancer Inst 2014;106:dju010. [PMID: 24594482 DOI: 10.1093/jnci/dju010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
75 Santilli F, Martellucci S, Di Pasquale J, Mei C, Liberati F, Protano C, Vitali M, Sorice M, Mattei V. Cancer Mortality Trend in Central Italy: Focus on A "Low Rate of Land Use" Area from 1982 to 2011. Int J Environ Res Public Health 2019;16:E628. [PMID: 30795508 DOI: 10.3390/ijerph16040628] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
76 Das V, Kalita J, Pal M. Predictive and prognostic biomarkers in colorectal cancer: A systematic review of recent advances and challenges. Biomed Pharmacother. 2017;87:8-19. [PMID: 28040600 DOI: 10.1016/j.biopha.2016.12.064] [Cited by in Crossref: 105] [Cited by in F6Publishing: 94] [Article Influence: 17.5] [Reference Citation Analysis]
77 Hoffmeister M, Holleczek B, Stock C, Zwink N, Stolz T, Stegmaier C, Brenner H. Utilization and determinants of follow-up colonoscopies within 6 years after screening colonoscopy: Prospective cohort study: Utilization and determinants of follow-up colonoscopies. Int J Cancer 2019;144:402-10. [DOI: 10.1002/ijc.31862] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
78 Berstad P, Løberg M, Larsen IK, Kalager M, Holme Ø, Botteri E, Bretthauer M, Hoff G. Long-term lifestyle changes after colorectal cancer screening: randomised controlled trial. Gut. 2015;64:1268-1276. [PMID: 25183203 DOI: 10.1136/gutjnl-2014-307376] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
79 Haug U. [Current evidence and development of colorectal cancer screening in Germany]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2018;61:1513-6. [PMID: 30327833 DOI: 10.1007/s00103-018-2832-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
80 Young GP, Senore C, Mandel JS, Allison JE, Atkin WS, Benamouzig R, Bossuyt PM, Silva MD, Guittet L, Halloran SP, Haug U, Hoff G, Itzkowitz SH, Leja M, Levin B, Meijer GA, O'Morain CA, Parry S, Rabeneck L, Rozen P, Saito H, Schoen RE, Seaman HE, Steele RJ, Sung JJ, Winawer SJ. Recommendations for a step-wise comparative approach to the evaluation of new screening tests for colorectal cancer. Cancer 2016;122:826-39. [PMID: 26828588 DOI: 10.1002/cncr.29865] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
81 Ladabaum U, Patel A, Mannalithara A, Sundaram V, Mitani A, Desai M. Predicting advanced neoplasia at colonoscopy in a diverse population with the National Cancer Institute colorectal cancer risk-assessment tool. Cancer. 2016;122:2663-2670. [PMID: 27219715 DOI: 10.1002/cncr.30096] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
82 Consedine NS, Tuck NL, Ragin CR, Spencer BA. Beyond the black box: a systematic review of breast, prostate, colorectal, and cervical screening among native and immigrant African-descent Caribbean populations. J Immigr Minor Health 2015;17:905-24. [PMID: 24522436 DOI: 10.1007/s10903-014-9991-0] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 6.3] [Reference Citation Analysis]
83 Horner-Johnson W, Dobbertin K, Lee JC, Andresen EM. Rural disparities in receipt of colorectal cancer screening among adults ages 50-64 with disabilities. Disabil Health J 2014;7:394-401. [PMID: 25065974 DOI: 10.1016/j.dhjo.2014.06.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
84 Ladabaum U, Mannalithara A, Meester RGS, Gupta S, Schoen RE. Cost-Effectiveness and National Effects of Initiating Colorectal Cancer Screening for Average-Risk Persons at Age 45 Years Instead of 50 Years. Gastroenterology. 2019;157:137-148. [PMID: 30930021 DOI: 10.1053/j.gastro.2019.03.023] [Cited by in Crossref: 57] [Cited by in F6Publishing: 47] [Article Influence: 19.0] [Reference Citation Analysis]
85 Tóth K, Barták BK, Tulassay Z, Molnár B. Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis. Expert Rev Mol Diagn 2016;16:239-52. [PMID: 26652067 DOI: 10.1586/14737159.2016.1132164] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
86 Bonelli L. Epidemiology and screening: what's new? Colorectal Dis 2015;17 Suppl 1:10-4. [PMID: 25511855 DOI: 10.1111/codi.12815] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
87 Coghlin C, Murray GI. Biomarkers of colorectal cancer: Recent advances and future challenges. Prot Clin Appl 2015;9:64-71. [DOI: 10.1002/prca.201400082] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
88 Malvezzi M, Bertuccio P, Rosso T, Rota M, Levi F, La Vecchia C, Negri E. European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women? Ann Oncol. 2015;26:779-786. [PMID: 25623049 DOI: 10.1093/annonc/mdv001] [Cited by in Crossref: 198] [Cited by in F6Publishing: 175] [Article Influence: 28.3] [Reference Citation Analysis]
89 Wu BU, Longstreth GF, Ngor EW. Screening colonoscopy versus sigmoidoscopy: implications of a negative examination for cancer prevention and racial disparities in average-risk patients. Gastrointest Endosc. 2014;80:852-861.e1-2. [PMID: 24814774 DOI: 10.1016/j.gie.2014.03.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
90 Swartz AW, Eberth JM, Strayer SM. Preventing colorectal cancer or early diagnosis: Which is best? A re-analysis of the U.S. Preventive Services Task Force Evidence Report. Preventive Medicine 2019;118:104-12. [DOI: 10.1016/j.ypmed.2018.10.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
91 Rabeneck L, Horton S, Zauber AG, Earle C. Colorectal Cancer. In: Gelband H, Jha P, Sankaranarayanan R, Horton S, editors. Disease Control Priorities, Third Edition (Volume 3): Cancer. The World Bank; 2015. pp. 101-19. [DOI: 10.1596/978-1-4648-0349-9_ch6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
92 Causada-Calo N, Bishay K, Albashir S, Al Mazroui A, Armstrong D. Association Between Age and Complications After Outpatient Colonoscopy. JAMA Netw Open 2020;3:e208958. [PMID: 32584409 DOI: 10.1001/jamanetworkopen.2020.8958] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
93 Aguado Loi CX, Adegoke KK, Gwede CK, Sappenfield WM, Bryant CA. Florida Populations Most at Risk of Not Being Up to Date With Colorectal Cancer Screening. Prev Chronic Dis 2018;15:E70. [PMID: 29862961 DOI: 10.5888/pcd15.170224] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
94 Ait Ouakrim D, Pizot C, Boniol M, Malvezzi M, Boniol M, Negri E, Bota M, Jenkins MA, Bleiberg H, Autier P. Trends in colorectal cancer mortality in Europe: retrospective analysis of the WHO mortality database. BMJ. 2015;351:h4970. [PMID: 26442928 DOI: 10.1136/bmj.h4970] [Cited by in Crossref: 93] [Cited by in F6Publishing: 86] [Article Influence: 13.3] [Reference Citation Analysis]
95 Taksler GB, Perzynski AT, Kattan MW. Modeling Individual Patient Preferences for Colorectal Cancer Screening Based on Their Tolerance for Complications Risk. Med Decis Making 2017;37:204-15. [PMID: 27879412 DOI: 10.1177/0272989X16679161] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
96 Murphy CC, Halm EA, Skinner CS, Balasubramanian BA, Singal AG. Challenges and Approaches to Measuring Repeat Fecal Immunochemical Test for Colorectal Cancer Screening. Cancer Epidemiol Biomarkers Prev 2020;29:1557-63. [PMID: 32457184 DOI: 10.1158/1055-9965.EPI-20-0230] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
97 Brenner H, Stock C, Hoffmeister M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ. 2014;348:g2467. [PMID: 24922745 DOI: 10.1136/bmj.g2467] [Cited by in Crossref: 375] [Cited by in F6Publishing: 329] [Article Influence: 46.9] [Reference Citation Analysis]
98 Nash SH, Britton C, Redwood D. Characteristics of colorectal cancers among Alaska Native people before and after implementing programs to promote screening. J Cancer Policy 2021;29:100293. [PMID: 34395191 DOI: 10.1016/j.jcpo.2021.100293] [Reference Citation Analysis]
99 Tao S, Hoffmeister M, Brenner H. Development and validation of a scoring system to identify individuals at high risk for advanced colorectal neoplasms who should undergo colonoscopy screening. Clin Gastroenterol Hepatol. 2014;12:478-485. [PMID: 24022090 DOI: 10.1016/j.cgh.2013.08.042] [Cited by in Crossref: 64] [Cited by in F6Publishing: 57] [Article Influence: 7.1] [Reference Citation Analysis]
100 Sung JJ, Ng SC, Chan FK, Chiu HM, Kim HS, Matsuda T, Ng SS, Lau JY, Zheng S, Adler S, Reddy N, Yeoh KG, Tsoi KK, Ching JY, Kuipers EJ, Rabeneck L, Young GP, Steele RJ, Lieberman D, Goh KL; Asia Pacific Working Group. An updated Asia Pacific Consensus Recommendations on colorectal cancer screening. Gut. 2015;64:121-132. [PMID: 24647008 DOI: 10.1136/gutjnl-2013-306503] [Cited by in Crossref: 214] [Cited by in F6Publishing: 216] [Article Influence: 26.8] [Reference Citation Analysis]
101 McGregor LM, Bonello B, Kerrison RS, Nickerson C, Baio G, Berkman L, Rees CJ, Atkin W, Wardle J, von Wagner C. Uptake of Bowel Scope (Flexible Sigmoidoscopy) Screening in the English National Programme: the first 14 months. J Med Screen. 2016;23:77-82. [PMID: 26387824 DOI: 10.1177/0969141315604659] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 4.9] [Reference Citation Analysis]
102 Xuan K, Zhao T, Sun C, Patel AS, Liu H, Chen X, Qu G, Sun Y. The association between hypertension and colorectal cancer: a meta-analysis of observational studies. European Journal of Cancer Prevention 2021;30:84-96. [DOI: 10.1097/cej.0000000000000578] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
103 Wang X, Häring MF, Rathjen T, Lockhart SM, Sørensen D, Ussar S, Rasmussen LM, Bertagnolli MM, Kahn CR, Rask-Madsen C. Insulin resistance in vascular endothelial cells promotes intestinal tumour formation. Oncogene 2017;36:4987-96. [PMID: 28459466 DOI: 10.1038/onc.2017.107] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
104 Haug U, Engel S, Verheyen F, Linder R. Estimating colorectal cancer treatment costs: a pragmatic approach exemplified by health insurance data from Germany. PLoS One 2014;9:e88407. [PMID: 24586324 DOI: 10.1371/journal.pone.0088407] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
105 Niedermaier T, Weigl K, Hoffmeister M, Brenner H. Diagnostic performance of flexible sigmoidoscopy combined with fecal immunochemical test in colorectal cancer screening: meta-analysis and modeling. Eur J Epidemiol 2017;32:481-93. [DOI: 10.1007/s10654-017-0279-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
106 Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet. 2014;383:1490-1502. [PMID: 24225001 DOI: 10.1016/s0140-6736(13)61649-9] [Cited by in Crossref: 1517] [Cited by in F6Publishing: 962] [Article Influence: 168.6] [Reference Citation Analysis]
107 Li C, Wang X, Casal I, Wang J, Li P, Zhang W, Xu E, Lai M, Zhang H. Growth differentiation factor 15 is a promising diagnostic and prognostic biomarker in colorectal cancer. J Cell Mol Med 2016;20:1420-6. [PMID: 26990020 DOI: 10.1111/jcmm.12830] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
108 Chen C, Stock C, Hoffmeister M, Brenner H. Public health impact of colonoscopy use on colorectal cancer mortality in Germany and the United States. Gastrointest Endosc. 2018;87:213-221.e2. [PMID: 28431951 DOI: 10.1016/j.gie.2017.04.005] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 5.2] [Reference Citation Analysis]
109 Ruco A, Walsh C, Cooper M, Rabeneck L. Training non-physicians to do endoscopy: Feasibility, effectiveness and cost-effectiveness. Best Practice & Research Clinical Gastroenterology 2016;30:389-96. [DOI: 10.1016/j.bpg.2016.04.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
110 Soraya GV, Nguyen TC, Abeyrathne CD, Huynh DH, Chan J, Nguyen PD, Nasr B, Chana G, Kwan P, Skafidas E. A Label-Free, Quantitative Fecal Hemoglobin Detection Platform for Colorectal Cancer Screening. Biosensors (Basel) 2017;7:E19. [PMID: 28475117 DOI: 10.3390/bios7020019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
111 Goede SL, Rabeneck L, Lansdorp-Vogelaar I, Zauber AG, Paszat LF, Hoch JS, Yong JH, van Hees F, Tinmouth J, van Ballegooijen M. The impact of stratifying by family history in colorectal cancer screening programs. Int J Cancer 2015;137:1119-27. [PMID: 25663135 DOI: 10.1002/ijc.29473] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
112 Warren Andersen S, Blot WJ, Lipworth L, Steinwandel M, Murff HJ, Zheng W. Association of Race and Socioeconomic Status With Colorectal Cancer Screening, Colorectal Cancer Risk, and Mortality in Southern US Adults. JAMA Netw Open 2019;2:e1917995. [PMID: 31860105 DOI: 10.1001/jamanetworkopen.2019.17995] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 10.3] [Reference Citation Analysis]
113 Del Vecchio Blanco G, Paoluzi OA, Sileri P, Rossi P, Sica G, Pallone F. Familial colorectal cancer screening: When and what to do? World J Gastroenterol 2015; 21(26): 7944-7953 [PMID: 26185367 DOI: 10.3748/wjg.v21.i26.7944] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
114 Von Renteln D, Bouin M, Barkun AN. Current standards and new developments of colorectal polyp management and resection techniques. Expert Rev Gastroenterol Hepatol. 2017;11:835-842. [PMID: 28319429 DOI: 10.1080/17474124.2017.1309279] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
115 Cisyk AL, Singh H, Mcmanus KJ. Establishing a Biological Profile for Interval Colorectal Cancers. Dig Dis Sci 2014;59:2390-402. [DOI: 10.1007/s10620-014-3210-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
116 Hissong E, Pittman ME. Colorectal carcinoma screening: Established methods and emerging technology. Crit Rev Clin Lab Sci 2020;57:22-36. [PMID: 31603697 DOI: 10.1080/10408363.2019.1670614] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
117 Tomašević R, Milosavljević T, Stojanović D, Gluvić Z, Dugalić P, Ilić I, Vidaković R. Predictive Value of Carcinoembryonic and Carbohydrate Antigen 19-9 Related to Some Clinical, Endoscopic and Histological Colorectal Cancer Characteristics. J Med Biochem 2016;35:324-32. [PMID: 28356884 DOI: 10.1515/jomb-2016-0014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
118 Ladabaum U, Shepard J, Mannalithara A. Adenoma and Serrated Lesion Detection by Colonoscopy Indication: The ADR-ESS (ADR Extended to all Screening/Surveillance) Score. Clin Gastroenterol Hepatol 2021;19:1873-82. [PMID: 33895358 DOI: 10.1016/j.cgh.2021.04.027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
119 Singal AG, Higgins PD, Waljee AK. A primer on effectiveness and efficacy trials. Clin Transl Gastroenterol 2014;5:e45. [PMID: 24384867 DOI: 10.1038/ctg.2013.13] [Cited by in Crossref: 294] [Cited by in F6Publishing: 265] [Article Influence: 36.8] [Reference Citation Analysis]
120 Malagón M, Ramió-Pujol S, Serrano M, Serra-Pagès M, Amoedo J, Oliver L, Bahí A, Mas-de-Xaxars T, Torrealba L, Gilabert P, Miquel-Cusachs JO, García-Nimo L, Saló J, Guardiola J, Piñol V, Cubiella J, Castells A, Aldeguer X, Garcia-Gil J. Reduction of faecal immunochemical test false-positive results using a signature based on faecal bacterial markers. Aliment Pharmacol Ther 2019;49:1410-20. [PMID: 31025420 DOI: 10.1111/apt.15251] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
121 Young GP, Woodman RJ, Symonds E. Detection of advanced colorectal neoplasia and relative colonoscopy workloads using quantitative faecal immunochemical tests: an observational study exploring the effects of simultaneous adjustment of both sample number and test positivity threshold. BMJ Open Gastroenterol 2020;7:e000517. [PMID: 32994195 DOI: 10.1136/bmjgast-2020-000517] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
122 Stracci F, Zorzi M, Grazzini G. Colorectal cancer screening: tests, strategies, and perspectives. Front Public Health. 2014;2:210. [PMID: 25386553 DOI: 10.3389/fpubh.2014.00210] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 5.9] [Reference Citation Analysis]
123 Forbes N, Cooray M, Hackett M, Shah N, Yuan Y, Antiperovitch P, Corner T, Chan D, Mills M, Armstrong D, Xenodemetropoulos T. An Electronic Clinical Decision-Making Tool for Patients with Suspected Colorectal Cancer-Preliminary Evaluation in Patients Presenting with Rectal Bleeding. J Can Assoc Gastroenterol 2020;3:204-9. [PMID: 32905126 DOI: 10.1093/jcag/gwz013] [Reference Citation Analysis]
124 Xin KP, Du ML, Liu ZY, Wang WR, Qian YG, Liu L, Lv YF, Sun J. Colorectal cancer mortality in Inner Mongolia between 2008 and 2012. World J Gastroenterol 2014; 20(25): 8209-8214 [PMID: 25009394 DOI: 10.3748/wjg.v20.i25.8209] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
125 Bénard F, Barkun AN, Martel M, von Renteln D. Systematic review of colorectal cancer screening guidelines for average-risk adults: Summarizing the current global recommendations. World J Gastroenterol 2018; 24(1): 124-138 [PMID: 29358889 DOI: 10.3748/wjg.v24.i1.124] [Cited by in CrossRef: 90] [Cited by in F6Publishing: 82] [Article Influence: 22.5] [Reference Citation Analysis]
126 Chen N, Kong Y, Wu Y, Gao Q, Fu J, Sun X, Geng Q. CAC1 knockdown reverses drug resistance through the downregulation of P-gp and MRP-1 expression in colorectal cancer. PLoS One 2019;14:e0222035. [PMID: 31504073 DOI: 10.1371/journal.pone.0222035] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
127 Greuter MJ, Berkhof J, Fijneman RJ, Demirel E, Lew JB, Meijer GA, Stoker J, Coupé VM. The potential of imaging techniques as a screening tool for colorectal cancer: a cost-effectiveness analysis. Br J Radiol 2016;89:20150910. [PMID: 27194458 DOI: 10.1259/bjr.20150910] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
128 Prakash MK, Lang B, Heinrich H, Valli PV, Bauerfeind P, Sonnenberg A, Beerenwinkel N, Misselwitz B. CMOST: an open-source framework for the microsimulation of colorectal cancer screening strategies. BMC Med Inform Decis Mak 2017;17:80. [PMID: 28583127 DOI: 10.1186/s12911-017-0458-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
129 Choi J, Jia G, Wen W, Long J, Shu XO, Zheng W. Effects of Screenings in Reducing Colorectal Cancer Incidence and Mortality Differ by Polygenic Risk Scores. Clin Transl Gastroenterol 2021;12:e00344. [PMID: 33955373 DOI: 10.14309/ctg.0000000000000344] [Reference Citation Analysis]